Solid Tumor Rules Changes for 2022 - Head and Neck

Patricia Hines, CTR Oncology Leave a Comment

Effective September 1, 2021, for all cases diagnosed January 1, 2022 and forward. Daily cancer abstracting requires the use of many manuals to abstract a patient’s case daily. One such manual is the Solid Tumor Rules manual by the Surveillance, Epidemiology, and End Results Program (SEER). The use of this manual, which according to the CancerRegistryeducation.org website,...

Telling a Patient’s Cancer Story in 8000 Characters or Less: The Use of Abbreviations in an Abstract

Patricia Hines, CTR Cancer Registry Leave a Comment

The daily struggle is real for cancer registrars with each abstract on how to stretch 1000 characters per text box while reporting a patient’s cancer story.  Eight thousand characters may sound like a lot until you start typing away. How many times did you focus on typing the patient’s information into a text box just to find out you already reached your 1000-character...

New Assigned Roles Within Rapid Cancer Reporting System (RCRS) Starts This Week

Patricia Hines, CTR Cancer Registry Leave a Comment

In September 2020, the well-known RQRS and NCDB Call for Data submissions programs were phased out with the release of the Commission on Cancer’s (COC) National Cancer Database (NCDB) new Rapid Cancer Reporting System (RCRS). The RQRS along with NCDB’s Call for Data, were both important tools used for quality improvement and real time reporting in accredited CoC...

Reportability of Pituitary Adenomas with Spontaneous Regression

Michele Webb, CTR Oncology Leave a Comment

Pituitary adenomas are tumors of the anterior pituitary gland. Most are slow-growing and benign. They are classified based on size or cell of origin and described as microadenoma, macroadenoma, or giant tumors. Microadenomas are usually less than 10 mm in size, while macroadenomas are larger than 10 mm. Giant pituitary tumors are bigger than 40 mm. Adenomas are further...

CoC Launches New Quality Measures in 2022

Michele Webb, CTR Oncology 1 Comment

The Commission on Cancer (CoC) requires accredited programs to treat cancer patients according to nationally accepted measures endorsed by the CoC. The measures are included in the Rapid Cancer Reporting System (RCRS) tool for monitoring and reporting purposes. Standard 7.1 states that each calendar year the expected performance rate should be met for each of the quality...

President’s Cancer Panel Addresses Gaps in Cancer Screening

Suzanne Neve, RHIA, CTR - Director, Cancer Registry Oncology Leave a Comment

Cancer screening saves lives and reduces the burden of cancer in the United States. However, gaps in screening programs mean far too many in the US are presenting with late-stage disease or dying from cancers that were preventable or could have been detected at an earlier stage. The socially and economically disadvantaged populations are often at higher risk for cancer...

Melanoma: A Primer for Cancer Registrars

Suzanne Neve, RHIA, CTR - Director, Cancer Registry Oncology Leave a Comment

Melanoma is a type of skin cancer that arises in the melanocytes or cells that produce melanin and determines the color of your skin, or pigment. Melanoma can form in the eyes, and on rare occasions inside the body such as the nose or throat. Its exact causes are not always clear, but evidence does support exposure to ultraviolet (UV) radiation from sunlight or tanning...

Navigating Rivers of Change at the NCRA 2022 Annual Conference

Suzanne Neve, RHIA, CTR - Director, Cancer Registry NCRA Leave a Comment

On April 6, 2022, the National Cancer Registrar’s Association (NCRA) will kick off its annual educational conference at the Gaylord National Resort and Convention Center in Washington, DC. This year’s conference will offer a first-time ever hybrid experience where virtual attendees can watch the live streaming of the in-person sessions and take part in the live Q&A. Early...

Concurrent Abstracting

Cindy Zahn, MS Oncology Leave a Comment

When I first heard about concurrent abstracting years ago, I thought “they have got to be kidding”. Now, many years later, it is my reality. I have been doing concurrent abstracting since December of 2016. Although concurrent abstracting has many advantages, there are also disadvantages.  What is Concurrent Abstracting? Concurrent abstracting is when you complete the...

Cancer Prevention and Screening a Mixed Bag in 2021

Suzanne Neve, RHIA, CTR - Director, Cancer Registry Oncology Leave a Comment

According to the American Cancer Society (ACS) estimates, 608,570 deaths will occur from cancer in the United States in 2021. About 45% are attributed to potentially preventable, pre-pandemic causes such as tobacco smoking, obesity, alcohol intake, physical inactivity, and an unhealthy diet. In the ACS report Cancer Prevention and Early Detection Facts & Figures,...

Sign Up For MRA Blog Updates!

Recent Posts